Stock Events

Stock Events

Lantheus 

$100.87
209
+$0.07+0.07% Tuesday 20:00
+$0.00+0%Tuesday 23:30After hours

Statistics

Day High
100.92
Day Low
100.87
52W High
111.86
52W Low
49.67
Volume
16,473
Avg. Volume
-
Mkt Cap
6.58B
P/E Ratio
25.21
Dividend Yield
-
Dividend
-

Upcoming

Earnings

29OctExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
1.23
1.38
1.53
1.68
Expected EPS
1.258055
Actual EPS
N/A

Financials

15.15%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
1.54BRevenue
233.56MNet Income

Analyst Ratings

112.80Average Price Target
The highest estimate is 129.00.
From 7 ratings within the last 6 months. This is not an investment recommendation.
Buy
29%
Hold
71%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow LNTH. It's not an investment recommendation.
Amazon
41
AMZN
NVIDIA
39
NVDA
Apple
36
AAPL
Microsoft
36
MSFT

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
GE Aerospace
GE
Mkt Cap361.46B
General Electric, through its healthcare division, produces diagnostic imaging agents and radiopharmaceuticals for imaging modalities that compete with Lantheus' products.
Koninklijke Philips N.V.
PHG
Mkt Cap26.8B
Philips, with its healthcare division, provides advanced molecular imaging solutions and diagnostics that rival Lantheus' offerings.
Shoulder Innovations
SI
Mkt Cap418.08M
Siemens Healthineers offers a broad spectrum of diagnostic imaging agents and equipment, competing in the same space as Lantheus.
Bruker
BRKR
Mkt Cap9.07B
Bruker Corporation engages in the development of life science analytical and diagnostic products, some of which are in direct competition with Lantheus' technologies.
Thermo Fisher Scientific
TMO
Mkt Cap232.67B
Thermo Fisher Scientific offers products and services in the diagnostics and healthcare sector, including imaging chemicals and supplies that compete with Lantheus.
Abbvie
ABBV
Mkt Cap468.22B
AbbVie, through its acquisition of Allergan, has entered into areas that overlap with Lantheus' interests, particularly in diagnostics and therapeutic solutions.
Danaher
DHR
Mkt Cap153.85B
Danaher, with its portfolio of life sciences and diagnostics companies, competes in the development and marketing of medical imaging and diagnostics solutions.
Johnson & Johnson
JNJ
Mkt Cap651.25B
Johnson & Johnson, through its medical devices and diagnostics segments, offers products that compete in the imaging and diagnostics field.
Astrazeneca
AZN
Mkt Cap257.42B
AstraZeneca, while primarily focused on pharmaceuticals, has ventures in personalized healthcare and diagnostics that could compete with Lantheus' diagnostic imaging solutions.

About

Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.
Show more...
CEO
Mary Anne Heino
Employees
1193
Country
United States
ISIN
US5165441032
WKN
000A117UE

Listings

MI
IT
1LNTH.MI
F
DE
0L8.F
XETRA
DE
0L8.XETRA
STU
DE
0L8.STU

0 Comments

Share your thoughts

FAQ

What is Lantheus stock price today?▼
The current price of LNTH is $100.87 USD — it has increased by +0.07% in the past 24 hours. Watch Lantheus stock price performance more closely on the chart.
What is Lantheus stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Lantheus stocks are traded under the ticker LNTH.
Is Lantheus stock price growing?▼
LNTH stock has risen by +0.39% compared to the previous week, the month change is a -3.77% fall, over the last year Lantheus has showed a +81.17% increase.
What is Lantheus market cap?▼
Today Lantheus has the market capitalization of 6.58B
When is the next Lantheus earnings date?▼
Lantheus is going to release the next earnings report on October 29, 2026.
What were Lantheus earnings last quarter?▼
LNTH earnings for the last quarter are 1.55 USD per share, whereas the estimation was 1.3 USD resulting in a +18.9% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Lantheus revenue for the last year?▼
Lantheus revenue for the last year amounts to 1.54B USD.
What is Lantheus net income for the last year?▼
LNTH net income for the last year is 233.56M USD.
How many employees does Lantheus have?▼
As of August 26, 2026, the company has 1,193 employees.
In which sector is Lantheus located?▼
Lantheus operates in the Health & Wellness sector.
When did Lantheus complete a stock split?▼
Lantheus has not had any recent stock splits.
Where is Lantheus headquartered?▼
Lantheus is headquartered in NORTH BILLERICA, United States.